EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
How EY can help
-
Discover M&A advisory services from EY when you buy and integrate. We help enable strategic growth through integrated mergers and acquisitions, joint ventures and alliances.
Read more
On November 28, 2024, it was announced that SyntheticMR AB (publ, listed on the XSAT in Stockholm, Sweden) has signed an agreement to acquire Finnish company Combinostics Oy, a leading medical technology and software solutions company focusing on cloud-based and AI-driven platforms.
The acquisition allows SyntheticMR to strengthen its market position and future competitiveness by combining the technology and expertise of both companies. The total purchase price for the acquisition amounts to EUR 4.3 million, with EUR 3.93 million paid in cash and the remaining EUR 0.37 million settled through a promissory note, which will later be converted into shares.
Combinostics, known for its advanced diagnostic tools and clinical decision support solutions, will bring additional value to SyntheticMR’s offerings, particularly in the diagnosis of neurodegenerative diseases such as MS and dementia.
EY provided financial and tax due diligence support to SyntheticMR during the transaction process.
The transaction is expected to close around January 2025 and is subject to customary conditions, including the approval of SyntheticMR's general meeting.
More informaton can be found on SyntheticMR's press release.
Below you can find a selection of EY's recent deal alerts and you can also find a more extensive list on our Strategy and Transactions page.